Primary refractory or relapsed acute myeloid leukemia is associated with a dismal
prognosis. Allogeneic stem cell transplantation is the only therapeutic option that offers …

We studied patients with acute myeloid leukemia (AML) over age 50 and in first complete
remission (CR1) after adult unrelated donor (URD)(n= 441, 8/8 HLA matched; n= 94, 7/8 …

Results of reduced intensity conditioning regimen (RIC) in the HLA identical haematopoietic
stem cell transplantation (HSCT) setting have not been compared to those after …

We analyzed retrospectively data from 1696 patients with AML transplanted in Europe from
January 1987 to December 1992 and reported to the acute leukemia EBMT registry. Groups …

Purpose To investigate the influence of donor type (human leukocyte antigen [HLA]-identical
sibling donor versus HLA-A–, HLA-B–, HLA-Cw–, HLA-DRB1–, and HLA-DQB1–identical …

Allogeneic hematopoietic cell transplantation is widely used to treat adults with high-risk
acute lymphoblastic leukemia. The aim of this study was to analyze whether the results …

Transplantation of hematopoietic stem cells from an HLA-compatible unrelated volunteer is
an option for patients with acute leukemia lacking a family match. However, criteria for …

Background In the absence of a HLA-matched related or matched unrelated donor,
allogeneic stem cell transplantation (allo-SCT) from mismatched unrelated donors or …

Background Allogenic hematopoietic stem cell transplantation (allo-SCT) is the most
effective post-remission treatment for adults with high-risk acute lymphoblastic leukemia …

Between 1996 and 2004, a total of 708 patients were enrolled in the acute myeloid
leukaemia (AML)'96 and '02 studies of the East German Study Group (OSHO). Of these, 138 …